Literature DB >> 22582012

Vitamin K2 is a mitochondrial electron carrier that rescues pink1 deficiency.

Melissa Vos1, Giovanni Esposito, Janaka N Edirisinghe, Sven Vilain, Dominik M Haddad, Jan R Slabbaert, Stefanie Van Meensel, Onno Schaap, Bart De Strooper, R Meganathan, Vanessa A Morais, Patrik Verstreken.   

Abstract

Human UBIAD1 localizes to mitochondria and converts vitamin K(1) to vitamin K(2). Vitamin K(2) is best known as a cofactor in blood coagulation, but in bacteria it is a membrane-bound electron carrier. Whether vitamin K(2) exerts a similar carrier function in eukaryotic cells is unknown. We identified Drosophila UBIAD1/Heix as a modifier of pink1, a gene mutated in Parkinson's disease that affects mitochondrial function. We found that vitamin K(2) was necessary and sufficient to transfer electrons in Drosophila mitochondria. Heix mutants showed severe mitochondrial defects that were rescued by vitamin K(2), and, similar to ubiquinone, vitamin K(2) transferred electrons in Drosophila mitochondria, resulting in more efficient adenosine triphosphate (ATP) production. Thus, mitochondrial dysfunction was rescued by vitamin K(2) that serves as a mitochondrial electron carrier, helping to maintain normal ATP production.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22582012     DOI: 10.1126/science.1218632

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  129 in total

Review 1.  Mitochondrial dysfunction in Parkinson's disease: molecular mechanisms and pathophysiological consequences.

Authors:  Nicole Exner; Anne Kathrin Lutz; Christian Haass; Konstanze F Winklhofer
Journal:  EMBO J       Date:  2012-06-26       Impact factor: 11.598

2.  Plasticity of the quinone-binding site of the complex II homolog quinol:fumarate reductase.

Authors:  Prashant K Singh; Maruf Sarwar; Elena Maklashina; Violetta Kotlyar; Sany Rajagukguk; Thomas M Tomasiak; Gary Cecchini; Tina M Iverson
Journal:  J Biol Chem       Date:  2013-07-08       Impact factor: 5.157

Review 3.  Mitochondrial protein quality control in health and disease.

Authors:  Michael J Baker; Catherine S Palmer; Diana Stojanovski
Journal:  Br J Pharmacol       Date:  2014-04       Impact factor: 8.739

Review 4.  New approaches for studying synaptic development, function, and plasticity using Drosophila as a model system.

Authors:  C Andrew Frank; Xinnan Wang; Catherine A Collins; Avital A Rodal; Quan Yuan; Patrik Verstreken; Dion K Dickman
Journal:  J Neurosci       Date:  2013-11-06       Impact factor: 6.167

5.  Structure-activity relationship study of vitamin k derivatives yields highly potent neuroprotective agents.

Authors:  Benjamin J Josey; Elizabeth S Inks; Xuejun Wen; C James Chou
Journal:  J Med Chem       Date:  2013-01-30       Impact factor: 7.446

6.  Structural insights into ubiquinone biosynthesis in membranes.

Authors:  Wei Cheng; Weikai Li
Journal:  Science       Date:  2014-02-21       Impact factor: 47.728

7.  Acyl coenzyme A thioesterase 7 regulates neuronal fatty acid metabolism to prevent neurotoxicity.

Authors:  Jessica M Ellis; G William Wong; Michael J Wolfgang
Journal:  Mol Cell Biol       Date:  2013-03-04       Impact factor: 4.272

8.  Loss of Pink1 modulates synaptic mitochondrial bioenergetics in the rat striatum prior to motor symptoms: concomitant complex I respiratory defects and increased complex II-mediated respiration.

Authors:  Kelly L Stauch; Lance M Villeneuve; Phillip R Purnell; Brendan M Ottemann; Katy Emanuel; Howard S Fox
Journal:  Proteomics Clin Appl       Date:  2016-09-21       Impact factor: 3.494

9.  UBIAD1-mediated vitamin K2 synthesis is required for vascular endothelial cell survival and development.

Authors:  Jeffrey M Hegarty; Hongbo Yang; Neil C Chi
Journal:  Development       Date:  2013-04       Impact factor: 6.868

Review 10.  Analysis of mitochondrial structure and function in the Drosophila larval musculature.

Authors:  Zong-Heng Wang; Cheryl Clark; Erika R Geisbrecht
Journal:  Mitochondrion       Date:  2015-12-01       Impact factor: 4.160

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.